Advaxis Corp. (OTC BB: ADXS) CEO InterviewAdvaxis Corp. (OTC BB: ADXS) CEO InterviewThis interview has expired. Special deals for our readers Be a more profitable investor: Get an Equifax 3-in-1 Credit Report Now! Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing. Invest Smarter! Get 4 Bonus Weeks of Investor’s Business Daily Digital Edition! LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount. Get FICO Score Watch Now! Click here to get access to powerful investing tools only available at Investor’s Business Daily. Get a free look at Jim Cramer’s Action Alerts PLUS portfolio. Click here Advaxis Corp. Advaxis, Inc., formerly Great Expectations, Inc., is a development-stage biotechnology company focused on developing cancer vaccines that utilize mechanisms of immunity. The Company uses the Listeria system licensed from the University of Pennsylvania (Penn) to secrete a protein sequence containing a tumor-specific antigen. The Company has focused its initial development efforts upon cancer vaccines targeting cervical, head and neck, breast, prostate, and other cancers. Its products in development include Lovaxin C and Lovaxin B, Lovaxin P. |
|
Standard Podcast [15:34m]: 
WSR Recommends |
||
| Special Deal for Our Readers (That’s You!) | Jim Cramer: The Clown That Makes You Money | Get Rich with Fibonacci. Learn How to Use Fibonacci Analysis to Trade Better. |
